Drug Shortages Leave NHS Facing “New Reality” of Substitutes and Uncertainty
Persistent shortages of essential medicines are reshaping healthcare across the UK, with experts warning that the NHS is being forced to manage scarcity rather than prevent it.
Reliable access to medication remains a cornerstone of modern healthcare, yet supply disruptions continue to affect patients nationwide. Experts say around 60% of shortages stem from manufacturing bottlenecks, alongside fluctuating demand, regulatory pressures and global instability. Limited reserves of both finished medicines and raw ingredients have further exposed vulnerabilities in the system.
Concerns have reached the highest levels of government. A recent report by the House of Lords called for stronger national leadership on medicine supply, warning that shortages are not being treated with the urgency of a national security issue despite clear risks to public health.
Existing measures, including the National Supply Disruption Response protocol, allow GPs and pharmacists to offer alternative treatments or delay starting patients on medicines in short supply. However, clinicians say these steps merely ease the pressure rather than addressing the root causes.
The issue is compounded by the number of patients who remain on long-term prescriptions that may no longer be necessary. While reducing medication—known as de-prescribing—could help free up supply, the process must be gradual and carefully managed, limiting its short-term impact.
The UK’s reliance on overseas production has added further strain. A significant proportion of medicines are manufactured abroad, often concentrated in countries such as India, Israel and Ireland, leaving supply chains vulnerable during global disruptions.
Recent shortages have affected a wide range of treatments, including Ritalin, propranolol, and drugs used in hormone replacement therapy, diabetes and epilepsy. Around 120 medicines are currently reported to be in short supply across the UK.
Clinicians warn that substituting medicines is not always straightforward. Even when alternatives exist, differences in formulation—such as immediate-release versus extended-release—can significantly affect how drugs are absorbed, how long they last, and the side-effects patients experience. For some, switching medications may lead to reduced effectiveness or withdrawal symptoms.
Healthcare professionals are urging better guidance on safe alternatives and clearer communication with patients to manage expectations.
Experts say long-term solutions will require sustained investment in domestic manufacturing and greater diversification of international supply chains. Without decisive action, shortages are likely to remain a defining challenge for the NHS.